- Home
- Middle East And Africa Thyroid Ablation Devices Market
Middle East and Africa Thyroid Ablation Devices Market - Industry Trends and Forecast to 2028
- Published Date: September, 2022 | Report ID: CLS-331 | No of pages: 150 | Format:
Middle East and Africa thyroid ablation devices market is projected to register a substantial CAGR of 9.7% in the forecast period of 2021 to 2028. The new market report contains data for the historic year 2019, the base year of calculation is 2020 and the forecast period is 2021 to 2028
Market Segmentation:
Middle East and Africa Thyroid Ablation Devices Market, By Disease (Benign Thyroid Nodules, Thyroid Cancers), Product Type (Thermal Based Devices, Non-Thermal Based Devices), Modality (Fixed, Standalone, Portable), Type (Radiofrequency Ablation, Laser or Light Ablation, Ultrasound Ablation, Cryoablation, Electrical Ablation, Microwave Ablation, Hydrothermal Ablation, Others), End User (Hospitals and Surgical Centers, Oncology Centers, Clinics, Community Healthcare, Others), Distribution Channel (Direct Sales, Third Party Distributor), Country (Saudi Arabia, South Africa, UAE, Israel, Kuwait, Egypt and Rest of Middle East and Africa) Industry Trends & Forecast to 2028
Some of the major factors contributing to the growth of the Europe thyroid ablation devices market are:
Advancement in ablation techniques
Reimbursement given for ablation
Market Players:
The key market players for Middle East and Africa thyroid ablation devices market are listed below:
Medtronic
Biosense Webster, Inc
Boston Scientific Corporation
Olympus Coropration
Smith & Nephew
Koninklijke Philips N.V.
BIOTRONIK SE & Co. KG
Terumo Europe NV (a subsidiary of Terumo Corporation)
Stryker
Merit Medical Systems
IceCure Medical
Biosense Webster, Inc. (a subsidiary of Johnson & Johnson Services, Inc.)
TABLE OF CONTENT
TABLE OF CONTENTS 1 INTRODUCTION 1.1 OBJECTIVES OF THE STUDY 1.2 MARKET DEFINITION 1.3 OVERVIEW OF MIDDLE EAST & AFRICA THYROID ABLATION DEVICES MARKET 1.4 LIMITATIONS 1.5 MARKETS COVERED 2 MARKET SEGMENTATION 2.1 MARKETS COVERED 2.2 GEOGRAPHICAL SCOPE 2.3 YEARS CONSIDERED FOR THE STUDY 2.4 CURRENCY AND PRICING 2.5 DBMR TRIPOD DATA VALIDATION MODEL 2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 2.7 MULTIVARIATE MODELLING 2.8 DISEASE LIFELINE CURVE 2.9 DBMR MARKET POSITION GRID 2.10 MARKET END USER COVERAGE GRID 2.11 VENDOR SHARE ANALYSIS 2.12 SECONDARY SOURCES 2.13 ASSUMPTIONS 3 EXECUTIVE SUMMARY 4 NUMBER OF PROCEDURES (2019-2028) 5 MIDDLE EAST & AFRICA THYROID ABLATION DEVICES MARKET: REGULATORY FRAMEWORK 5.1 THE IRELAND REGULATORY SCENARIO FOR TREATING ABLATION DEVICES FOR THYROID CANCER TREATMENT 5.2 THE U.K. REGULATORY SCENARIO FOR THYROID ABLATION DEVICES 5.3 THE BRITISH THYROID ASSOCIATION HAS PUBLISHED SPECIFIC VITAL REGULATORY GUIDELINES IN 2014: 5.4 SNM PRACTICE GUIDELINE FOR THERAPY OF THYROID DISEASE WITH 131I 3.0: 5.5 SPAIN REGULATORY SCENARIO FOR THYROID ABLATION DEVICES 5.6 ITALY REGULATORY SCENARIO FOR THYROID ABLATION DEVICES 6 EPIDEMIOLOGY 7 MARKET OVERVIEW 7.1 DRIVERS 7.1.1 INCREASING PREVALENCE OF THYROID NODULES & CANCER 7.1.2 ADVANCEMENTS IN ABLATION TECHNIQUES 7.1.3 INCREASING INVESTMENT IN R&D BY MARKET PARTICIPANTS 7.1.4 AVAILABILITY OF REIMBURSEMENT FOR ABLATION PROCEDURE 7.1.5 INCREASING HEALTHCARE EXPENDITURE 7.2 RESTRAINTS 7.2.1 HIGH COST OF THYROID NODULES ABLATION PROCEDURES 7.2.2 SIDE EFFECTS RELATED TO ABLATION TREATMENT 7.2.3 AVAILABILITY OF ALTERNATIVES 7.2.4 LACK OF AWARENESS FOR THYROID NODULES AND CANCER 7.3 OPPORTUNITIES 7.3.1 INCREASING GERIATRIC POPULATION 7.3.2 STRATEGIC INITIATIVES BY MARKET PLAYERS 7.3.3 INCREASED DEMAND FOR NON-INVASIVE PROCEDURE 7.4 CHALLENGES 7.4.1 LACK OF SKILLED PROFESSIONALS 7.4.2 LONG APPROVAL TIME ASSOCIATED WITH PRODUCT LAUNCH 8 IMPACT OF COVID-19 ON THE MIDDLE EAST & AFRICA THYROID ABLATION DEVICES MARKET 8.1 IMPACT ON PRICE 8.2 MPACT ON DEMAND 8.3 IMPACT ON SUPPLY CHAIN 8.4 STRATEGIC DECISION BY MANUFACTURERS 8.5 CONCLUSION 9 MIDDLE EAST & AFRICA THYROID ABLATION DEVICES MARKET, BY DISEASE 9.1 OVERVIEW 9.2 BENIGN THYROID NODULES 9.3 THYROID CANCER 10 MIDDLE EAST & AFRICA THYROID ABLATION DEVICES MARKET, BY PRODUCT TYPE 10.1 OVERVIEW 10.2 THERMAL BASED DEVICES 10.2.1 RADIOFREQUENCY 10.2.1.1 TEMPERATURE CONTROLLED-RADIOFREQUENCY ABLATORS 10.2.1.2 FLUID COOLED-RADIOFREQUENCY ABLATORS 10.2.1.3 ROBOTIC CATHETER MANIPULATION SYSTEMS 10.2.2 LASER/LIGHT ABLATORS 10.2.2.1 EXCIMER LASER ABLATORS 10.2.2.2 COLD LASER ABLATORS 10.2.3 ULTRASOUND ABLATORS 10.2.3.1 ULTRASONIC SURGICAL ABLATION SYSTEMS 10.2.3.2 HIGH-INTENSITY FOCUSED ULTRASOUND (HIFU) ABLATORS 10.2.3.3 EXTRACORPOREAL SHOCKWAVE LITHOTRIPSY (ESWL) SYSTEMS 10.2.3.4 MAGNETIC RESONANCE-GUIDED FOCUSED ULTRASOUND (MRGFUS) ABLATORS 10.2.4 MICROWAVE ABLATORS 10.2.5 ELECTRICAL ABLATORS 10.2.5.1 IRREVERSIBLE ELECTROPORATION ABLATORS 10.2.5.2 OTHERS 10.2.6 OTHERS 10.3 NON-THERMAL BASED DEVICES 10.3.1 CRYOABLATION DEVICES 10.3.1.1 TISSUE CONTACT 10.3.1.2 TISSUE SPRAY 10.3.1.3 EPIDERMAL AND SUBCUTANEOUS CRYOABLATION DEVICES 10.3.2 OTHERS 11 MIDDLE EAST & AFRICA THYROID ABLATION DEVICES MARKET, BY TYPE 11.1 OVERVIEW 11.2 RADIOFREQUENCY ABLATION 11.3 LASER OR LIGHT ABLATION 11.4 ULTRASOUND ABLATION 11.5 CRYOABLATION 11.6 ELECTRICAL ABLATION 11.7 MICROWAVE ABLATION 11.8 HYDROTHERMAL ABLATION 11.9 OTHERS 12 MIDDLE EAST & AFRICA THYROID ABLATION DEVICES MARKET, BY MODALITY 12.1 OVERVIEW 12.2 FIXED 12.3 PORTABLE 12.4 STANDALONE 13 MIDDLE EAST & AFRICA THYROID ABLATION DEVICES MARKET, BY END USER 13.1 OVERVIEW 13.2 HOSPITALS & SURGICAL CENTERS 13.2.1 RADIOLOGIST 13.2.2 SURGEON 13.2.3 ENDOCRINOLOGIST 13.2.4 NUCLEAR MEDICINE 13.3 ONCOLOGY CENTERS 13.4 CLINICS 13.5 COMMUNITY HEALTHCARE 13.6 OTHERS 14 MIDDLE EAST & AFRICA THYROID ABLATION DEVICES MARKET, BY DISTRIBUTION CHANNEL 14.1 OVERVIEW 14.2 DIRECT TENDER 14.3 THIRD PARTY DISTRIBUTOR 15 MIDDLE EAST & AFRICA THYROID ABLATION DEVICES MARKET, BY GEOGRAPHY 15.1 MIDDLE EAST & AFRICA 15.1.1 SOUTH AFRICA 15.1.2 SAUDI ARABIA 15.1.3 UAE 15.1.4 ISRAEL 15.1.5 EGYPT 15.1.6 REST OF MIDDLE EAST & AFRICA 16 MIDDLE EAST & AFRICA THYROID ABLATION DEVICES MARKET: COMPANY LANDSCAPE 16.1 COMPANY SHARE ANALYSIS: MIDDLE EAST & AFRICA 17 COMPANY PROFILE 17.1 TERUMO EUROPE NV (A SUBSIDIARY OF TERUMO CORPORATION) 17.1.1 COMPANY SNAPSHOT 17.1.2 REVENUE ANALYSIS 17.1.3 PRODUCT PORTFOLIO 17.1.4 RECENT DEVELOPMENT 17.2 BIOSENSE WEBSTER, INC. (A SUBSIDIARY OF JOHNSON & JOHNSON SERVICES, INC.) 17.2.1 COMPANY SNAPSHOT 17.2.2 REVENUE ANALYSIS 17.2.3 PRODUCT PORTFOLIO 17.2.4 RECENT DEVELOPMENTS 17.3 SMITH & NEPHEW 17.3.1 COMPANY SNAPSHOT 17.3.2 REVENUE ANALYSIS 17.3.3 PRODUCT PORTFOLIO 17.3.4 RECENT DEVELOPMENT 17.4 BIOTRONIK SE & CO. KG 17.4.1 COMPANY SNAPSHOT 17.4.2 PRODUCT PORTFOLIO 17.4.3 RECENT DEVELOPMENTS 17.5 MEDTRONIC 17.5.1 COMPANY SNAPSHOT 17.5.2 REVENUE ANALYSIS 17.5.3 PRODUCT PORTFOLIO 17.5.4 RECENT DEVELOPMENTS 17.6 MERIT MEDICAL SYSTEMS 17.6.1 COMPANY SNAPSHOT 17.6.2 REVENUE ANALYSIS 17.6.3 PRODUCT PORTFOLIO 17.6.4 RECENT DEVELOPMENTS 17.7 KONINKLIJKE PHILIPS N.V. 17.7.1 COMPANY SNAPSHOT 17.7.2 REVENUE ANALYSIS 17.7.3 PRODUCT PORTFOLIO 17.7.4 RECENT DEVELOPMENT 17.8 INTEGRA LIFESCIENCES CORPORATION 17.8.1 COMPANY SNAPSHOT 17.8.2 REVENUE ANALYSIS 17.8.3 PRODUCT PORTFOLIO 17.8.4 RECENT DEVELOPMENTS 17.9 BOSTON SCIENTIFIC CORPORATION 17.9.1 COMPANY SNAPSHOT 17.9.2 REVENUE ANALYSIS 17.9.3 PRODUCT PORTFOLIO 17.9.4 RECENT DEVELOPMENTS 17.10 CONMED CORPORATION 17.10.1 COMPANY SNAPSHOT 17.10.2 REVENUE ANALYSIS 17.10.3 PRODUCT PORTFOLIO 17.10.4 RECENT DEVELOPMENTS 17.11 OLYMPUS CORPORATION 17.11.1 COMPANY SNAPSHOT 17.11.2 REVENUE ANALYSIS 17.11.3 PRODUCT PORTFOLIO 17.11.4 RECENT DEVELOPMENTS 17.12 CARL ZEISS MEDITECH AG 17.12.1 COMPANY SNAPSHOT 17.12.2 REVENUE ANALYSIS 17.12.3 PRODUCT PORTFOLIO 17.12.4 RECENT DEVELOPMENTS 17.13 ATRICURE, INC. 17.13.1 COMPANY SNAPSHOT 17.13.2 REVENUE ANALYSIS 17.13.3 PRODUCT PORTFOLIO 17.13.4 RECENT DEVELOPMENTS 17.14 BAYLIS MEDICL COMPANY, INC. 17.14.1 COMPANY SNAPSHOT 17.14.2 PRODUCT PORTFOLIO 17.14.3 RECENT DEVELOPMENTS 17.15 ANGIODYNAMICS 17.15.1 COMPANY SNAPSHOT 17.15.2 REVENUE ANALYSIS 17.15.3 PRODUCT PORTFOLIO 17.15.4 RECENT DEVELOPMENTS 17.16 CHONGQUING HAIFU MEDICAL TECHNOLOGY CO., LTD. 17.16.1 COMPANY SNAPSHOT 17.16.2 PRODUCT PORTFOLIO 17.16.3 RECENT DEVELOPMENTS 17.17 DIREXGROUP 17.17.1 COMPANY SNAPSHOT 17.17.2 PRODUCT PORTFOLIO 17.17.3 RECENT DEVELOPMENTS 17.18 ICECURE MEDICAL 17.18.1 COMPANY SNAPSHOT 17.18.2 REVENUE ANALYSIS 17.18.3 PRODUCT PORTFOLIO 17.18.4 RECENT DEVELOPMENTS 17.19 IMRICOR 17.19.1 COMPANY SNAPSHOT 17.19.2 REVENUE ANALYSIS 17.19.3 PRODUCT PORTFOLIO 17.19.4 RECENT DEVELOPMENT 17.20 LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD. 17.20.1 COMPANY SNAPSHOT 17.20.2 REVENUE ANALYSIS 17.20.3 PRODUCT PORTFOLIO 17.20.4 RECENT DEVELOPMENTS 17.21 MECHAN EUROPE LTD 17.21.1 COMPANY SNAPSHOT 17.21.2 PRODUCT PORTFOLIO 17.21.3 RECENT DEVELOPMENTS 17.22 STRYKER 17.22.1 COMPANY SNAPSHOT 17.22.2 REVENUE ANALYSIS 17.22.3 PRODUCT PORTFOLIO 17.22.4 RECENT DEVELOPMENTS 17.23 SONACARE MEDICAL 17.23.1 COMPANY SNAPSHOT 17.23.2 PRODUCT PORTFOLIO 17.23.3 RECENT DEVELOPMENTS 17.24 THERACLION 17.24.1 COMPANY SNAPSHOT 17.24.2 REVENUE ANALYSIS 17.24.3 PRODUCT PORTFOLIO 17.24.4 RECENT DEVELOPMENTS 17.25 TROD MEDICAL 17.25.1 COMPANY SNAPSHOT 17.25.2 PRODUCT PORTFOLIO 17.25.3 RECENT DEVELOPMENTS 18 SWOT 19 QUESTIONNAIRE 20 RELATED REPORTSSegmentation
Short Description Middle East and Africa Thyroid Ablation Devices Market, By Disease (Benign Thyroid Nodules, Thyroid Cancers), Product Type (Thermal Based Devices, Non-Thermal Based Devices), Modality (Fixed, Standalone, Portable), Type (Radiofrequency Ablation, Laser or Light Ablation, Ultrasound Ablation, Cryoablation, Electrical Ablation, Microwave Ablation, Hydrothermal Ablation, Others), End User (Hospitals and Surgical Centers, Oncology Centers, Clinics, Community Healthcare, Others), Distribution Channel (Direct Sales, Third Party Distributor), Country (Saudi Arabia, South Africa, UAE, Israel, Kuwait, Egypt and Rest of Middle East and Africa) Industry Trends & Forecast to 2028 Market Definition: Tumor ablation is a minimally invasive procedure for treating tumors of the liver, kidney, bone and lung as well as other soft tissue glands. The ablation technique is used to treat thyroid nodules and cancer. A thyroid nodule is a lump of thyroid cells that has developed abnormally in the thyroid gland. Normal thyroid tissue may often begin to develop, resulting in the development of one or more nodules. Market Segmentation: The thyroid ablation devices market is categorized into six notable segments which are based on the basis of disease, product type, modality, type, end user and distribution channel. On the basis of disease, the thyroid ablation devices market is segmented into benign thyroid nodules and thyroid cancers On the basis of product type, the thyroid ablation devices market is segmented into thermal based devices and non-thermal based devices On the basis of type, the thyroid ablation devices market is segmented into radiofrequency ablation, laser or light ablation, ultrasound ablation, electrical ablation, cryoablation, microwave ablation, hydrothermal ablation and others On the basis of modality, the thyroid ablation devices market is segmented into portable, fixed and standalone On the basis of end user, the thyroid ablation devices market is segmented into hospitals and surgical centers, oncology centers, clinics, community healthcare and others On the basis of distribution channel, the thyroid ablation devices market is segmented into direct sales and third party distributor Market Players The key market players for Middle East and Africa thyroid ablation devices market are listed below: Medtronic Biosense Webster, Inc Boston Scientific Corporation Olympus Coropration Smith & Nephew Koninklijke Philips N.V. BIOTRONIK SE & Co. KG Terumo Europe NV (a subsidiary of Terumo Corporation) Stryker Merit Medical Systems IceCure Medical Biosense Webster, Inc. (a subsidiary of Johnson & Johnson Services, Inc.)Methodology
Why Choose Us
24 * 7 Access to Analyst :
Get your pre and post sales queries resolved by our Subject matter experts.
Customization :
We will assist you to customize the report to fit your research needs.
Assured Quality :
Our prime focus is to provide qualitative and accurate data.
Free sample report :
Feel free to order a sample report before purchase.
Security :
Your personal and confidential information is safe and secured.
© 2025 Cognate Lifesciences. All Rights Reserved.